查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1812383

醫藥合約銷售外包市場

Pharmaceutical Contract Sales Outsourcing Market
出版日期: | 出版商: Transparency Market Research | 英文 190 Pages | 商品交期: 2-10個工作天內

價格

醫藥合約銷售外包市場-報告範圍

TMR 關於全球醫藥合約銷售外包市場的報告研究了過去和當前的成長趨勢和機遇，以獲得 2025 年至 2035 年預測期內市場指標的寶貴見解。該報告提供了 2025 年至 2035 年期間全球醫藥合約銷售外包市場的收入，以 2025 年為基準年，2035 年為預測年。該報告也提供了 2025 年至 2035 年全球醫藥合約銷售外包市場的年複合成長率(CAGR %)。

本報告經過廣泛的研究後編寫。主要研究工作量較大，分析師訪問了關鍵意見領袖、產業領袖和輿論領袖。次要研究則參考了主要廠商的產品資料、年度報告、新聞稿和相關文件，以了解二輪車導航顯示器市場。

市場概況
2024年的市場價值 109億美元
2035年的市場價值 248億美元
複合年成長率 7.7%

本報告深入探討了全球二輪車導航顯示器市場的競爭格局。報告已確定全球醫藥合約銷售外包市場的主要參與者，並根據其各項屬性對每位參與者進行了分析。本報告涵蓋了公司概況、財務狀況、近期發展和 SWOT 分析等內容，涵蓋了全球醫藥合約銷售外包市場參與者的各項屬性。

全球醫藥合約銷售外包市場報告解答的關鍵問題：

  • 預測期內，所有地區的血液分離術銷售額/收入為何？
  • 全球二輪車導航顯示器市場有哪些機會？
  • 市場的主要促進因素、限制因素、機會和威脅是什麼？
  • 在預測期內，哪個區域市場將以最快的複合年成長率擴張？
  • 預計哪個領域將在 2035 年創造全球最高收入？
  • 預測期內，哪個細分市場預計以最高複合年成長率擴張？
  • 在全球市場中經營的不同公司的市場地位如何？

醫藥合約銷售外包市場-研究目標和研究方法

這份關於全球醫藥合約銷售外包市場的綜合報告首先概述了研究範圍和目標。報告詳細闡述了本研究的目標、市場中的主要供應商和分銷商，以及產品核准的監管情況。

為了方便閱讀，本報告採用章節式編排，每個章節又細分為多個小節。報告包含詳盡的圖表，並適當穿插。各關鍵細分市場的實際值和預測值以圖形方式呈現，視覺上引人入勝。此外，報告也便於讀者比較過去和預測期末各關鍵細分市場的市佔率。

本報告從產品、最終用戶和地區角度分析了全球醫藥合約銷售外包市場。該報告對每個標準下的關鍵細分市場進行了深入研究，並提供了2035年底每個細分市場的市場佔有率。這些寶貴的見解使市場利益相關者能夠在全球二輪車導航顯示器市場投資時做出明智的商業決策。

目錄

第1章：前言

第2章：假設與研究方法

第3章：執行摘要：全球市場

第4章：市場概況

  • 介紹
  • 概述
  • 市場動態
  • 2020年至2035年全球醫藥合約銷售外包市場分析與預測

第5章：關鍵見解

  • 主要地區/國家的醫療保健支出
  • 醫藥銷售外包的優勢
  • 波特五力分析
  • 大環境分析
  • 重要產業事件（合作夥伴關係、協作、產品核准、併購）

第6章：全球市場分析與預測：依服務類型

  • 介紹與定義
  • 主要發現/進展
  • 2020 年至 2035 年按服務類型分類的市場價值預測
    • 個人推廣
      • 促銷銷售團隊
        • 專業的銷售團隊
        • 聯合銷售團隊
      • 大客戶管理
      • 空缺管理
    • 非個人推銷
      • 電話諮詢
      • 互動式電子細節
      • 客戶服務
      • 醫學科學聯絡員
      • 病人參與服務
      • 其他
    • 其他
  • 各服務類型的市場吸引力

第7章：全球市場分析與預測：依治療領域

  • 介紹與定義
  • 主要發現/進展
  • 2020 年至 2035 年按治療領域分類的市場價值預測
    • 心血管疾病
    • 腫瘤疾病
    • 呼吸系統疾病
    • 代謝紊亂
    • 神經系統疾病
    • 骨科疾病
    • 傳染病
    • 其他
  • 各治療領域的市場吸引力

第8章：全球市場分析與預測：按最終用戶

  • 介紹與定義
  • 主要發現/進展
  • 2020 年至 2035 年終端用戶市場價值預測
    • 製藥公司
      • 新藥開發商
      • 學名藥開發商
      • 疫苗開發商
    • 生技公司
  • 最終用戶的市場吸引力

第9章：全球市場分析與預測：按地區

  • 主要發現
  • 各地區市場價值預測
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 各地區市場吸引力

第10章：北美市場分析與預測

  • 美國
  • 加拿大

第 11 章：歐洲市場分析與預測

  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 瑞士
  • 荷蘭
  • 歐洲其他地區

第 12 章：亞太市場分析與預測

  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲和紐西蘭
  • 亞太其他地區

第13章：拉丁美洲市場分析與預測

  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區

第 14 章：中東和非洲市場分析與預測

  • 海灣合作理事會國家
  • 南非
  • 中東和非洲其他地區

第 15 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 各公司市佔率分析（2024年）
  • 公司簡介
    • IQVIA
    • Axxelus
    • EPS Corporation (EPS Holdings, Inc.)
    • Syneos Health
    • EVERSANA
    • CMIC HOLDINGS Co., LTD.
    • QFR Solutions
    • Sales Focus Inc.
    • GTS Solution
    • Mercalis
    • MaBiCo
    • Mednext Pharmaceuticals Pvt. Ltd.
    • Peak Pharma Solutions Inc.
    • Promoveo Health
    • Agilify Solutions Inc.
Product Code: TMRGL28562

Pharmaceutical Contract Sales Outsourcing Market- Scope of Report

TMR's report on the global Pharmaceutical Contract Sales Outsourcing Marketstudies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global Pharmaceutical Contract Sales Outsourcing Marketfor the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Pharmaceutical Contract Sales Outsourcing Marketfrom 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Pharmaceutical Contract Sales Outsourcing Market .

Market Snapshot
Market Value in 2024US$ 10.9 Bn
Market Value in 2035US$ 24.8 Bn
CAGR7.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Pharmaceutical Contract Sales Outsourcing Market .

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Pharmaceutical Contract Sales Outsourcing Market . These serve as valuable tools for existing Market players as well as for entities interested in participating in the global Pharmaceutical Contract Sales Outsourcing Market .

The report delves into the competitive landscape of the global Pharmaceutical Contract Sales Outsourcing Market . Key players operating in the global Pharmaceutical Contract Sales Outsourcing Markethave been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Pharmaceutical Contract Sales Outsourcing Marketprofiled in this report.

Key Questions Answered in Global Pharmaceutical Contract Sales Outsourcing MarketReport:

  • What are the opportunities in the global Pharmaceutical Contract Sales Outsourcing Market ?
  • What are the major drivers, restraints, opportunities, and threats in the Market ?
  • Which regional Market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the Market positions of different companies operating in the global Market ?

Pharmaceutical Contract Sales Outsourcing Market- Research Objectives and Research Approach

The comprehensive report on the global Pharmaceutical Contract Sales Outsourcing Marketbegins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Pharmaceutical Contract Sales Outsourcing Marketin terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the global Pharmaceutical Contract Sales Outsourcing Market .

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Pharmaceutical Contract Sales Outsourcing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Pharmaceutical Contract Sales Outsourcing Market Analysis and Forecasts, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Healthcare Expenditure across Key Regions / Countries
  • 5.2. Advantages of Pharmaceutical Sales Outsourcing
  • 5.3. PORTER's Five Forces Analysis
  • 5.4. PESTLE Analysis
  • 5.5. Key Industry Events (Partnership, Collaborations, Product approvals, merger & acquisitions)

6. Global Pharmaceutical Contract Sales Outsourcing Market Analysis and Forecasts, By Service Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Service Type, 2020 to 2035
    • 6.3.1. Personal Promotion
      • 6.3.1.1. Promotional Sales Team
        • 6.3.1.1.1. Dedicated Sales Team
        • 6.3.1.1.2. Syndicated Sales Team
      • 6.3.1.2. Key Account Management
      • 6.3.1.3. Vacancy Management
    • 6.3.2. Non-Personal Promotion
      • 6.3.2.1. Tele-detailing
      • 6.3.2.2. Interactive E-Detailing
      • 6.3.2.3. Customer Service
      • 6.3.2.4. Medical Science Liaisons
      • 6.3.2.5. Patient Engagement Services
      • 6.3.2.6. Others
    • 6.3.3. Others
  • 6.4. Market Attractiveness By Service Type

7. Global Pharmaceutical Contract Sales Outsourcing Market Analysis and Forecasts, By Therapeutic Area

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Therapeutic Area, 2020 to 2035
    • 7.3.1. Cardiovascular Disorders
    • 7.3.2. Oncological Disorders
    • 7.3.3. Respiratory Disorders
    • 7.3.4. Metabolic Disorders
    • 7.3.5. Neurological Disorders
    • 7.3.6. Orthopedic Disorders
    • 7.3.7. Infectious Diseases
    • 7.3.8. Others
  • 7.4. Market Attractiveness By Therapeutic Area

8. Global Pharmaceutical Contract Sales Outsourcing Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2020 to 2035
    • 8.3.1. Pharmaceutical Companies
      • 8.3.1.1. Novel Drug Developers
      • 8.3.1.2. Generic Drug Developers
      • 8.3.1.3. Vaccine Developers
    • 8.3.2. Biotechnology Companies
  • 8.4. Market Attractiveness By End-user

9. Global Pharmaceutical Contract Sales Outsourcing Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Region

10. North America Pharmaceutical Contract Sales Outsourcing Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Service Type, 2020 to 2035
    • 10.2.1. Personal Promotion
      • 10.2.1.1. Promotional Sales Team
        • 10.2.1.1.1. Dedicated Sales Team
        • 10.2.1.1.2. Syndicated Sales Team
      • 10.2.1.2. Key Account Management
      • 10.2.1.3. Vacancy Management
    • 10.2.2. Non-Personal Promotion
      • 10.2.2.1. Tele-detailing
      • 10.2.2.2. Interactive E-Detailing
      • 10.2.2.3. Customer Service
      • 10.2.2.4. Medical Science Liaisons
      • 10.2.2.5. Patient Engagement Services
      • 10.2.2.6. Others
    • 10.2.3. Others
  • 10.3. Market Value Forecast By Therapeutic Area, 2020 to 2035
    • 10.3.1. Cardiovascular Disorders
    • 10.3.2. Oncological Disorders
    • 10.3.3. Respiratory Disorders
    • 10.3.4. Metabolic Disorders
    • 10.3.5. Neurological Disorders
    • 10.3.6. Orthopedic Disorders
    • 10.3.7. Infectious Diseases
    • 10.3.8. Others
  • 10.4. Market Value Forecast By End-user, 2020 to 2035
    • 10.4.1. Pharmaceutical Companies
      • 10.4.1.1. Novel Drug Developers
      • 10.4.1.2. Generic Drug Developers
      • 10.4.1.3. Vaccine Developers
    • 10.4.2. Biotechnology Companies
  • 10.5. Market Value Forecast By Country, 2020 to 2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Service Type
    • 10.6.2. By Therapeutic Area
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Pharmaceutical Contract Sales Outsourcing Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Service Type, 2020 to 2035
    • 11.2.1. Personal Promotion
      • 11.2.1.1. Promotional Sales Team
        • 11.2.1.1.1. Dedicated Sales Team
        • 11.2.1.1.2. Syndicated Sales Team
      • 11.2.1.2. Key Account Management
      • 11.2.1.3. Vacancy Management
    • 11.2.2. Non-Personal Promotion
      • 11.2.2.1. Tele-detailing
      • 11.2.2.2. Interactive E-Detailing
      • 11.2.2.3. Customer Service
      • 11.2.2.4. Medical Science Liaisons
      • 11.2.2.5. Patient Engagement Services
      • 11.2.2.6. Others
    • 11.2.3. Others
  • 11.3. Market Value Forecast By Therapeutic Area, 2020 to 2035
    • 11.3.1. Cardiovascular Disorders
    • 11.3.2. Oncological Disorders
    • 11.3.3. Respiratory Disorders
    • 11.3.4. Metabolic Disorders
    • 11.3.5. Neurological Disorders
    • 11.3.6. Orthopedic Disorders
    • 11.3.7. Infectious Diseases
    • 11.3.8. Others
  • 11.4. Market Value Forecast By End-user, 2020 to 2035
    • 11.4.1. Pharmaceutical Companies
      • 11.4.1.1. Novel Drug Developers
      • 11.4.1.2. Generic Drug Developers
      • 11.4.1.3. Vaccine Developers
    • 11.4.2. Biotechnology Companies
  • 11.5. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Switzerland
    • 11.5.7. The Netherlands
    • 11.5.8. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Service Type
    • 11.6.2. By Therapeutic Area
    • 11.6.3. By End-user
    • 11.6.4. By Country / Sub-region

12. Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Service Type, 2020 to 2035
    • 12.2.1. Personal Promotion
      • 12.2.1.1. Promotional Sales Team
        • 12.2.1.1.1. Dedicated Sales Team
        • 12.2.1.1.2. Syndicated Sales Team
      • 12.2.1.2. Key Account Management
      • 12.2.1.3. Vacancy Management
    • 12.2.2. Non-Personal Promotion
      • 12.2.2.1. Tele-detailing
      • 12.2.2.2. Interactive E-Detailing
      • 12.2.2.3. Customer Service
      • 12.2.2.4. Medical Science Liaisons
      • 12.2.2.5. Patient Engagement Services
      • 12.2.2.6. Others
    • 12.2.3. Others
  • 12.3. Market Value Forecast By Therapeutic Area, 2020 to 2035
    • 12.3.1. Cardiovascular Disorders
    • 12.3.2. Oncological Disorders
    • 12.3.3. Respiratory Disorders
    • 12.3.4. Metabolic Disorders
    • 12.3.5. Neurological Disorders
    • 12.3.6. Orthopedic Disorders
    • 12.3.7. Infectious Diseases
    • 12.3.8. Others
  • 12.4. Market Value Forecast By End-user, 2020 to 2035
    • 12.4.1. Pharmaceutical Companies
      • 12.4.1.1. Novel Drug Developers
      • 12.4.1.2. Generic Drug Developers
      • 12.4.1.3. Vaccine Developers
    • 12.4.2. Biotechnology Companies
  • 12.5. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. South Korea
    • 12.5.5. Australia & New Zealand
    • 12.5.6. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Service Type
    • 12.6.2. By Therapeutic Area
    • 12.6.3. By End-user
    • 12.6.4. By Country / Sub-region

13. Latin America Pharmaceutical Contract Sales Outsourcing Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Service Type, 2020 to 2035
    • 13.2.1. Personal Promotion
      • 13.2.1.1. Promotional Sales Team
        • 13.2.1.1.1. Dedicated Sales Team
        • 13.2.1.1.2. Syndicated Sales Team
      • 13.2.1.2. Key Account Management
      • 13.2.1.3. Vacancy Management
    • 13.2.2. Non-Personal Promotion
      • 13.2.2.1. Tele-detailing
      • 13.2.2.2. Interactive E-Detailing
      • 13.2.2.3. Customer Service
      • 13.2.2.4. Medical Science Liaisons
      • 13.2.2.5. Patient Engagement Services
      • 13.2.2.6. Others
    • 13.2.3. Others
  • 13.3. Market Value Forecast By Therapeutic Area, 2020 to 2035
    • 13.3.1. Cardiovascular Disorders
    • 13.3.2. Oncological Disorders
    • 13.3.3. Respiratory Disorders
    • 13.3.4. Metabolic Disorders
    • 13.3.5. Neurological Disorders
    • 13.3.6. Orthopedic Disorders
    • 13.3.7. Infectious Diseases
    • 13.3.8. Others
  • 13.4. Market Value Forecast By End-user, 2020 to 2035
    • 13.4.1. Pharmaceutical Companies
      • 13.4.1.1. Novel Drug Developers
      • 13.4.1.2. Generic Drug Developers
      • 13.4.1.3. Vaccine Developers
    • 13.4.2. Biotechnology Companies
  • 13.5. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Argentina
    • 13.5.4. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Service Type
    • 13.6.2. By Therapeutic Area
    • 13.6.3. By End-user
    • 13.6.4. By Country / Sub-region

14. Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Service Type, 2020 to 2035
    • 14.2.1. Personal Promotion
      • 14.2.1.1. Promotional Sales Team
        • 14.2.1.1.1. Dedicated Sales Team
        • 14.2.1.1.2. Syndicated Sales Team
      • 14.2.1.2. Key Account Management
      • 14.2.1.3. Vacancy Management
    • 14.2.2. Non-Personal Promotion
      • 14.2.2.1. Tele-detailing
      • 14.2.2.2. Interactive E-Detailing
      • 14.2.2.3. Customer Service
      • 14.2.2.4. Medical Science Liaisons
      • 14.2.2.5. Patient Engagement Services
      • 14.2.2.6. Others
    • 14.2.3. Others
  • 14.3. Market Value Forecast By Therapeutic Area, 2020 to 2035
    • 14.3.1. Cardiovascular Disorders
    • 14.3.2. Oncological Disorders
    • 14.3.3. Respiratory Disorders
    • 14.3.4. Metabolic Disorders
    • 14.3.5. Neurological Disorders
    • 14.3.6. Orthopedic Disorders
    • 14.3.7. Infectious Diseases
    • 14.3.8. Others
  • 14.4. Market Value Forecast By End-user, 2020 to 2035
    • 14.4.1. Pharmaceutical Companies
      • 14.4.1.1. Novel Drug Developers
      • 14.4.1.2. Generic Drug Developers
      • 14.4.1.3. Vaccine Developers
    • 14.4.2. Biotechnology Companies
  • 14.5. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Service Type
    • 14.6.2. By Therapeutic Area
    • 14.6.3. By End-user
    • 14.6.4. By Country / Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. IQVIA
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Axxelus
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. EPS Corporation (EPS Holdings, Inc.)
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Syneos Health
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. EVERSANA
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. CMIC HOLDINGS Co., LTD.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. QFR Solutions
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Sales Focus Inc.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. GTS Solution
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Mercalis
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. MaBiCo
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Product Portfolio
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. Mednext Pharmaceuticals Pvt. Ltd.
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Product Portfolio
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. Peak Pharma Solutions Inc.
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Product Portfolio
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments
    • 15.3.14. Promoveo Health
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Financial Overview
      • 15.3.14.3. Product Portfolio
      • 15.3.14.4. Business Strategies
      • 15.3.14.5. Recent Developments
    • 15.3.15. Agilify Solutions Inc.
      • 15.3.15.1. Company Overview
      • 15.3.15.2. Financial Overview
      • 15.3.15.3. Product Portfolio
      • 15.3.15.4. Business Strategies
      • 15.3.15.5. Recent Developments

List of Tables

  • Table 01: Global Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Service Type, 2020 to 2035
  • Table 02: Global Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Personal Promotion, 2020 to 2035
  • Table 03: Global Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Promotional Sales Team, 2020 to 2035
  • Table 04: Global Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Non-Personal Promotion, 2020 to 2035
  • Table 05: Global Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Therapeutic Area, 2020 to 2035
  • Table 06: Global Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 07: Global Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Pharmaceutical Companies, 2020 to 2035
  • Table 08: Global Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
  • Table 09: North America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, by Country, 2020 to 2035
  • Table 10: North America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Service Type, 2020 to 2035
  • Table 11: North America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Personal Promotion, 2020 to 2035
  • Table 12: North America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Promotional Sales Team, 2020 to 2035
  • Table 13: North America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Non-Personal Promotion, 2020 to 2035
  • Table 14: North America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Therapeutic Area, 2020 to 2035
  • Table 15: North America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 16: North America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Pharmaceutical Companies, 2020 to 2035
  • Table 17: Europe Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 18: Europe Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Service Type, 2020 to 2035
  • Table 19: Europe Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Personal Promotion, 2020 to 2035
  • Table 20: Europe Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Promotional Sales Team, 2020 to 2035
  • Table 21: Europe Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Non-Personal Promotion, 2020 to 2035
  • Table 22: Europe Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Therapeutic Area, 2020 to 2035
  • Table 23: Europe Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 24: Europe Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Pharmaceutical Companies, 2020 to 2035
  • Table 25: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 26: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Service Type, 2020 to 2035
  • Table 27: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Personal Promotion, 2020 to 2035
  • Table 28: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Promotional Sales Team, 2020 to 2035
  • Table 29: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Non-Personal Promotion, 2020 to 2035
  • Table 30: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Therapeutic Area, 2020 to 2035
  • Table 31: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 32: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Pharmaceutical Companies, 2020 to 2035
  • Table 33: Latin America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 34: Latin America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Service Type, 2020 to 2035
  • Table 35: Latin America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Personal Promotion, 2020 to 2035
  • Table 36: Latin America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Promotional Sales Team, 2020 to 2035
  • Table 37: Latin America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Non-Personal Promotion, 2020 to 2035
  • Table 38: Latin America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Therapeutic Area, 2020 to 2035
  • Table 39: Latin America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 40: Latin America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Pharmaceutical Companies, 2020 to 2035
  • Table 41: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 42: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Service Type, 2020 to 2035
  • Table 43: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Personal Promotion, 2020 to 2035
  • Table 44: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Promotional Sales Team, 2020 to 2035
  • Table 45: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Non-Personal Promotion, 2020 to 2035
  • Table 46: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Therapeutic Area, 2020 to 2035
  • Table 47: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 48: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Pharmaceutical Companies, 2020 to 2035

List of Figures

  • Figure 01: Global Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Service Type, 2024 and 2035
  • Figure 02: Global Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Service Type, 2025 to 2035
  • Figure 03: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Personal Promotion, 2020 to 2035
  • Figure 04: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Non-Personal Promotion, 2020 to 2035
  • Figure 05: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 06: Global Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 07: Global Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
  • Figure 08: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Cardiovascular Disorders, 2020 to 2035
  • Figure 09: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Oncological Disorders, 2020 to 2035
  • Figure 10: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Respiratory Disorders, 2020 to 2035
  • Figure 11: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Metabolic Disorders, 2020 to 2035
  • Figure 12: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Neurological Disorders, 2020 to 2035
  • Figure 13: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Orthopedic Disorders, 2020 to 2035
  • Figure 14: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Infectious Diseases, 2020 to 2035
  • Figure 15: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 16: Global Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 17: Global Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 18: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Pharmaceutical Companies, 2020 to 2035
  • Figure 19: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Biotechnology Companies, 2020 to 2035
  • Figure 20: Global Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 21: Global Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 22: North America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 23: North America Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 24: North America Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 25: North America Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Service Type, 2024 and 2035
  • Figure 26: North America Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Service Type, 2025 to 2035
  • Figure 27: North America Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 28: North America Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
  • Figure 29: North America Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 30: North America Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 31: Europe Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 32: Europe Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 33: Europe Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 34: Europe Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Service Type, 2024 and 2035
  • Figure 35: Europe Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Service Type, 2025 to 2035
  • Figure 36: Europe Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 37: Europe Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
  • Figure 38: Europe Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 39: Europe Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 40: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 41: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 42: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 43: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Service Type, 2024 and 2035
  • Figure 44: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Service Type, 2025 to 2035
  • Figure 45: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 46: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
  • Figure 47: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 48: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 49: Latin America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 50: Latin America Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 51: Latin America Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 52: Latin America Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Service Type, 2024 and 2035
  • Figure 53: Latin America Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Service Type, 2025 to 2035
  • Figure 54: Latin America Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 55: Latin America Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
  • Figure 56: Latin America Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 57: Latin America Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 58: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 59: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 60: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 61: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Service Type, 2024 and 2035
  • Figure 62: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Service Type, 2025 to 2035
  • Figure 63: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 64: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
  • Figure 65: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 66: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By End-user, 2025 to 2035